Clinical Trials Directory

Trials / Completed

CompletedNCT00511589

Chagas Disease Diagnostic - Inconclusive Serology

PCR in Blood Cultures of Individuals With Positive and Inconclusive Serology for Chagas' Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
UPECLIN HC FM Botucatu Unesp · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

T. cruzi infection affects approximately five million people in Brazil. The diagnosis of the chronic phase of infection is performed by indirect serological methods which, nevertheless, leave inconclusive results. One of the direct methods used for T. cruzi identification, blood culture in LIT (liver infusion tryptose) medium, presents low sensitivity in that phase of the disease. A negative result does not eliminate the possibility of infection, but a positive test has high absolute diagnostic value, which enables the indication of antiparasitic treatment. Molecular diagnosis (PCR) in this phase is promising and can be used as a confirmatory test, particularly when individuals present inconclusive results in conventional serological tests, such as ELISA, HAI and IFI. This study aimed at improving blood culture sensitivity in LIT medium by performing PCR in individuals with positive and inconclusive serology for chagasic infection.

Conditions

Interventions

TypeNameDescription
OTHERchagas disease diagnostic

Timeline

First posted
2007-08-06
Last updated
2011-03-24

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00511589. Inclusion in this directory is not an endorsement.